Browsing Ponencias by Author "Maggi, Jaxaira"

Now showing items 1-15 of 15

Dendritic cells from rheumatoid arthritis patients conditioned with dexamethasone and activated with monophosphoryl lipid-A, exhibit strong migratory capacity and impaired T cell responses to synovial

Autor: García-González, Paulina A; Maggi, Jaxaira; Tobar, Pia; Catalán, Diego Francisco; Schinnerling, Katina; Aguillón-Gutiérrez, Juan Carlos Año: 2014N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Dexamethasone and monophosphoryl lipid A (MPLA) induce a regulatory profile on dendritic cells modulating genes associated to cell recruitment, signaling and metabolism.

Autor: García-González, Paulina A; Maggi, Jaxaira; Tobar, Pia; Catalán, Diego Francisco; Schinnerling, Katina; Aguillón-Gutiérrez, Juan Carlos Año: 2017N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Dexamethasone and monophosphoryl lipid A-modulated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells.

Autor: Aguillón-Gutiérrez, Juan Carlos; Maggi, Jaxaira; Schinnerling, Katina; Catalán, Diego Francisco Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Dexamethasone-conditioned monophosphoryl lipid A-activated dendritic cells derived from rheumatoid arthritis patients exhibit tolerogenic features and induce poor T cell responses to synovial antigens

Autor: Aguillón-Gutiérrez, Juan Carlos; García-González, Paulina A; Morales, Rodrigo A; Maggi, Jaxaira; Hoyos, Lorena; Tobar, Pia; Soto, Lilian; Pesce, Barbara; Catalán, Diego Francisco; Schinnerling, Katina Año: 2014N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Dexamethasone-modulated and monophosphoryl lipid A-activated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells

Autor: Maggi, Jaxaira; Schinnerling, Katina; Catalán, Diego Francisco; Aguillón-Gutiérrez, Juan Carlos Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Dexamethasone-modulated dendritic cells from rheumatoid arthritis patients activated with monophosphoryl lipid-A, display migratory capacity and induce reduced T cell responses to synovial antigens

Autor: García-González, Paulina A; Maggi, Jaxaira; Tobar, Pia; Catalán, Diego Francisco; Schinnerling, Katina; Aguillón-Gutiérrez, Juan Carlos Año: 2014N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Dexamethasone-treated and monophosphoryl lipid a-activated dendritic cells induce antigen-specific naive CD4+ T cells hyporesponsiveness

Autor: Maggi, Jaxaira; Pesce, Barbara; Schinnerling, Katina; Pino-Lago, Karina; Catalán, Diego Francisco; Aguillón-Gutiérrez, Juan Carlos Año: 2014N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Differential transcriptional analysis in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A.

Autor: Sepúlveda-Gutiérrez, Alejandro; García-González, Paulina A; Schinnerling, Katina; Maggi, Jaxaira; Ubilla-Olguín, Gabriela; Soto, Lilian; Catalán, Diego Francisco; Verdugo, Ricardo A; Aguillón-Gutiérrez, Juan Carlos Año: 2015N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Differential transcriptional programs in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A.

Autor: García-González, Paulina A; Schinnerling, Katina; Sepúlveda-Gutiérrez, Alejandro; Maggi, Jaxaira; Soto, Lilian; Neira, Oscar; Aguillón-Gutiérrez, Juan Carlos Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Distribution of HLA-DR alleles among chilean patients with rheumatoid arthritis

Autor: Maggi, Jaxaira; Aravena, O; Rivas, E; Schinnerling, Katina; Catalán, Diego Francisco; Soto, Lilian; Aguillón-Gutiérrez, Juan Carlos Año: 2017N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells.

Autor: Ubilla-Olguín, Gabriela; Schinnerling, Katina; Maggi, Jaxaira; García-González, Paulina A; Sepúlveda-Gutiérrez, Alejandro; Verdugo, Ricardo A; Aguillón-Gutiérrez, Juan Carlos Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid a-activated dendritic cells.

Autor: Ubilla-Olguín, Gabriela; Schinnerling, Katina; Maggi, Jaxaira; García-González, Paulina A; Sepúlveda-Gutiérrez, Alejandro; Verdugo, Ricardo A; Aguillón-Gutiérrez, Juan Carlos Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells.

Autor: Ubilla-Olguín, Gabriela; Schinnerling, Katina; Maggi, Jaxaira; García-González, Paulina A; Sepúlveda-Gutiérrez, Alejandro; Verdugo, Ricardo A; Aguillón-Gutiérrez, Juan Carlos Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
TLR-2 as potential tolerogenic marker for dexamethasone- modulated and monophosphoryl lipid A-activated dendritic cells

Autor: Maggi, Jaxaira; García-González, Paulina A; Ubilla-Olguín, Gabriela; Schinnerling, Katina; Sepúlveda-Gutiérrez, Alejandro; Verdugo, Ricardo A; Catalán, Diego Francisco; Aguillón-Gutiérrez, Juan Carlos Año: 2017N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT
Transcriptional programs of monocyte-derived tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects obtained by modulation with dexamethasone and monophosphoryl lipid A.

Autor: Aguillón-Gutiérrez, Juan Carlos; Schinnerling, Katina; García-González, Paulina A; Sepúlveda-Gutiérrez, Alejandro; Maggi, Jaxaira; Mehdi, Ahmed M; Nel, Hendrik J; Thomas, Ranjeny; Verdugo, Ricardo A Año: 2016N° de proyecto: 1140553Tipo: PonenciaPrograma: FONDECYT

Repositorio ANID Producción científica asociada a proyectos y becas financiadas por ANID

Browsing Ponencias by Author "Maggi, Jaxaira"

Dendritic cells from rheumatoid arthritis patients conditioned with dexamethasone and activated with monophosphoryl lipid-A, exhibit strong migratory capacity and impaired T cell responses to synovial

Dexamethasone and monophosphoryl lipid A (MPLA) induce a regulatory profile on dendritic cells modulating genes associated to cell recruitment, signaling and metabolism.

Dexamethasone and monophosphoryl lipid A-modulated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells.

Dexamethasone-conditioned monophosphoryl lipid A-activated dendritic cells derived from rheumatoid arthritis patients exhibit tolerogenic features and induce poor T cell responses to synovial antigens

Dexamethasone-modulated and monophosphoryl lipid A-activated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells

Dexamethasone-modulated dendritic cells from rheumatoid arthritis patients activated with monophosphoryl lipid-A, display migratory capacity and induce reduced T cell responses to synovial antigens

Dexamethasone-treated and monophosphoryl lipid a-activated dendritic cells induce antigen-specific naive CD4+ T cells hyporesponsiveness

Differential transcriptional analysis in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A.

Differential transcriptional programs in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A.

Distribution of HLA-DR alleles among chilean patients with rheumatoid arthritis

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells.

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid a-activated dendritic cells.

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells.

TLR-2 as potential tolerogenic marker for dexamethasone- modulated and monophosphoryl lipid A-activated dendritic cells

Transcriptional programs of monocyte-derived tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects obtained by modulation with dexamethasone and monophosphoryl lipid A.

Guía de búsquedas avanzadas

Browsing Ponencias by Author "Maggi, Jaxaira"

Dendritic cells from rheumatoid arthritis patients conditioned with dexamethasone and activated with monophosphoryl lipid-A, exhibit strong migratory capacity and impaired T cell responses to synovial ﻿

Dexamethasone and monophosphoryl lipid A (MPLA) induce a regulatory profile on dendritic cells modulating genes associated to cell recruitment, signaling and metabolism. ﻿

Dexamethasone and monophosphoryl lipid A-modulated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells. ﻿

Dexamethasone-conditioned monophosphoryl lipid A-activated dendritic cells derived from rheumatoid arthritis patients exhibit tolerogenic features and induce poor T cell responses to synovial antigens ﻿

Dexamethasone-modulated and monophosphoryl lipid A-activated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells ﻿

Dexamethasone-modulated dendritic cells from rheumatoid arthritis patients activated with monophosphoryl lipid-A, display migratory capacity and induce reduced T cell responses to synovial antigens ﻿

Dexamethasone-treated and monophosphoryl lipid a-activated dendritic cells induce antigen-specific naive CD4+ T cells hyporesponsiveness ﻿

Differential transcriptional analysis in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A. ﻿

Differential transcriptional programs in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A. ﻿

Distribution of HLA-DR alleles among chilean patients with rheumatoid arthritis ﻿

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells. ﻿

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid a-activated dendritic cells. ﻿

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells. ﻿

TLR-2 as potential tolerogenic marker for dexamethasone- modulated and monophosphoryl lipid A-activated dendritic cells ﻿

Transcriptional programs of monocyte-derived tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects obtained by modulation with dexamethasone and monophosphoryl lipid A. ﻿

Dendritic cells from rheumatoid arthritis patients conditioned with dexamethasone and activated with monophosphoryl lipid-A, exhibit strong migratory capacity and impaired T cell responses to synovial

Dexamethasone and monophosphoryl lipid A (MPLA) induce a regulatory profile on dendritic cells modulating genes associated to cell recruitment, signaling and metabolism.

Dexamethasone and monophosphoryl lipid A-modulated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells.

Dexamethasone-conditioned monophosphoryl lipid A-activated dendritic cells derived from rheumatoid arthritis patients exhibit tolerogenic features and induce poor T cell responses to synovial antigens

Dexamethasone-modulated and monophosphoryl lipid A-activated dendritic cells promote antigen-specific tolerogenic properties on naïve and memory CD4+ T cells

Dexamethasone-modulated dendritic cells from rheumatoid arthritis patients activated with monophosphoryl lipid-A, display migratory capacity and induce reduced T cell responses to synovial antigens

Dexamethasone-treated and monophosphoryl lipid a-activated dendritic cells induce antigen-specific naive CD4+ T cells hyporesponsiveness

Differential transcriptional analysis in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A.

Differential transcriptional programs in tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects modulated with dexamethasone and monophosphoryl lipid A.

Distribution of HLA-DR alleles among chilean patients with rheumatoid arthritis

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells.

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid a-activated dendritic cells.

Identifying markers of tolerogenicity in dexamethasone-modulated monophosphoryl lipid A-activated dendritic cells.

TLR-2 as potential tolerogenic marker for dexamethasone- modulated and monophosphoryl lipid A-activated dendritic cells

Transcriptional programs of monocyte-derived tolerogenic dendritic cells from rheumatoid arthritis patients and healthy subjects obtained by modulation with dexamethasone and monophosphoryl lipid A.